NATURE’S SUNSHINE PRODUCTS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$19.74 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2014-11-06
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-09-30 was -$8.21M.
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-06-30 was -$6.95M.
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-03-31 was -$4.59M.
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2013-12-31 was -$4.03M.
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$8.56M.
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2012 was -$2.99M.
- NATURE’S SUNSHINE PRODUCTS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2011 was -$1.68M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2014-09-30 | -$8.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$15.15M derived: sum of 2 quarters · filed 2014-11-06 | -$19.74M 10-Q · filed 2014-11-06 | -$23.77M derived: sum of 4 quarters · filed 2014-11-06 |
| 2014-06-30 | -$6.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$11.53M 10-Q · filed 2014-08-07 | -$15.56M derived: sum of 3 quarters · filed 2014-08-07 | -$17.73M derived: sum of 4 quarters · filed 2014-11-06 |
| 2014-03-31 | -$4.59M 10-Q · filed 2014-05-08 | -$8.62M derived: sum of 2 quarters · filed 2014-05-08 | -$10.79M derived: sum of 3 quarters · filed 2014-11-06 | -$11.91M derived: sum of 4 quarters · filed 2014-11-06 |
| 2013-12-31 | -$4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$6.20M derived: sum of 2 quarters · filed 2014-11-06 | -$7.32M derived: sum of 3 quarters · filed 2014-11-06 | -$8.56M 10-K · filed 2014-03-17 |
| 2013-09-30 | -$2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$3.29M derived: sum of 2 quarters · filed 2014-11-06 | -$4.54M 10-Q · filed 2014-11-06 | -$5.42M derived: sum of 4 quarters · filed 2014-11-06 |
| 2013-06-30 | -$1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$2.36M 10-Q · filed 2014-08-07 | -$3.25M derived: sum of 3 quarters · filed 2014-08-07 | -$6.21M derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | -$1.24M 10-Q · filed 2014-05-08 | -$2.13M derived: sum of 2 quarters · filed 2014-05-08 | -$5.08M derived: sum of 3 quarters · filed 2014-05-08 | -$6.61M derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | -$889.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$3.85M derived: sum of 2 quarters · filed 2014-03-17 | -$5.37M derived: sum of 3 quarters · filed 2014-03-17 | -$2.99M 10-K · filed 2014-03-17 |
| 2012-09-30 | -$2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$4.48M derived: sum of 2 quarters · filed 2013-11-08 | -$2.10M 10-Q · filed 2013-11-08 | -$4.45M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $856.00K 10-Q · filed 2013-08-09 | -$1.49M derived: sum of 3 quarters · filed 2014-03-17 | $338.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $2.38M 10-Q · filed 2013-05-09 | $35.00K derived: sum of 2 quarters · filed 2014-03-17 | $1.86M derived: sum of 3 quarters · filed 2014-03-17 | $224.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | -$2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$518.00K derived: sum of 2 quarters · filed 2014-03-17 | -$2.16M derived: sum of 3 quarters · filed 2014-03-17 | -$1.68M 10-K · filed 2014-03-17 |
| 2011-09-30 | $1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $189.00K derived: sum of 2 quarters · filed 2012-11-06 | $666.00K 10-Q · filed 2012-11-06 | |
| 2011-06-30 | -$1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$1.16M 10-Q · filed 2012-08-03 | ||
| 2011-03-31 | $477.00K 10-Q · filed 2012-05-08 | |||
| 2010-09-30 | -$2.01M 10-Q · filed 2011-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |